Explore the latest in atrial fibrillation, including advances in treatment and stroke prevention, recent guidelines, and long-term outcomes.
This narrative review examines the existing evidence of the differing response of embolic stroke of undetermined source to anticoagulation therapy and hypothesizes about pathophysiological factors that may underlie such variations.
This case report describes an adult woman with extensive skin lesions and epidermal spongiosis with neutrophilic and eosinophilic inflammation and telangiectasia from an allergic reaction to apixaban.
This open-label randomized trial compares the effect of pulmonary vein isolation via catheter ablation vs rate and rhythm control using drug therapy on the quality of life of patients with atrial fibrillation.
This randomized trial compares the effect of pulmonary vein isolation via catheter ablation vs rate and rhythm control using medical therapy on a composite outcome of death, disabling stroke, serious bleeding, or cardiac arrest in patients with atrial fibrillation (AF).
A man in his 70s with stage 4 chronic kidney disease and atrial fibrillation presented with 1 month of progressive dyspnea on exertion, orthopnea, and worsening lower extremity edema. What is your diagnosis?
This registry-based cohort study compares adverse event rates up to 3 years after initiation of treatment among patients receiving combination warfarin and aspirin therapy (without a therapeutic indication for aspirin use) vs those receiving warfarin monotherapy.
This registry-based cohort study assesses the differences in symptoms, treatment, and quality of life between Japanese men and women with atrial fibrillation.
This cohort study compares the risk of developing atrial fibrillation or major adverse cardiovascular events associated with ustekinumab vs a tumor necrosis factor (TNF) inhibitor therapy among patients with psoriasis or psoriatic arthritis.
This randomized trial compares the effects of pulmonary vein isolation using radiofrequency ablation vs antiarrhythmic medication on self-reported quality of life at 1 year in patients with atrial fibrillation and previous medication failure.
This JAMA Clinical Guidelines Synopsis summarizes the AHA/ACC/HRS 2019 update of the societies’ guideline for managing patients with atrial fibrillation, focusing on use of novel oral anticoagulants (NOACs) and procedural interventions such as left atrial appendage closure (LAAC) and catheter ablation.
This JAMA Patient Page describes why and how cardiac catheter ablation is used to correct atrial fibrillation and other heart rhythm abnormalities.
This phenome-wide association study determines polygenic predictors of thyrotropin levels and atrial fibrillation.
This Viewpoint discusses the use of electrocardiogram screening for atrial fibrillation, particularly in light of the US Preventive Services Task Force’s “insufficient evidence” recommendation regarding screening.
This mendelian randomization study evaluates the relationship between thyroid traits and atrial fibrillation.
This nested case-control study of patients with early-onset atrial fibrillation (AF) used large-scale, deep-coverage whole-genome sequencing to identify a loss-of-function variant in TTN, the gene encoding the rare nerve protein titin, as a genetic risk factor for early AF.
This study examines the incidence of atrial fibrillation in a cohort of elite athletes.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: